Research Details on XEPTAGEN SpA - Product Pipeline Analysis, 2016 Update

XEPTAGEN SpA - Product Pipeline Analysis, 2016 Update Size and Share Published in 2016-07-20 Available for US$ 750 at Researchmoz.us

Description

GET THE FULL REPORT : http://www.researchmoz.us/xeptagen-spa-product-pipeline-analysis-2016-update-report.html

Xeptagen SpA (Xeptagen) is a medical device company that discovers molecular markers. The company produces diagnostic kits for the monitoring, detection, and screening of cancerous cells. It develops an optoelectronic biochip for the determination of tumor molecular markers; and conducts research on developing biochips for the simultaneous detection of biomarkers-IgM immunecomplexes. Xeptagen uses combinatorial proteomic technology to discover prognostic, predictive and early response tumor markers. The company operates through several medical device and research organizations to develop its products. It conducts research for the treatment of liver cancer, colorectal cancer, and prostate cancer. Xeptagen is headquartered in Marghera, Italy.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.



Get a Free Sample Copy of the Report: http://www.researchmoz.us/enquiry.php?type=S&repid=789885



Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company XEPTAGEN SpA

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



Inquiry on this report: http://www.researchmoz.us/enquiry.php?type=E&repid=789885



Table of Content

Table of Contents 2

List of Tables 4

List of Figures 5

XEPTAGEN SpA Company Snapshot 6

XEPTAGEN SpA Company Overview 6

XEPTAGEN SpA Pipeline Products and Clinical Trials Overview 7

XEPTAGEN SpA Pipeline Analysis Overview 9

Key Facts 9

XEPTAGEN SpA - Major Products and Services 10

XEPTAGEN SpA Pipeline Products by Development Stage 11

XEPTAGEN SpA Pipeline Products Overview 13

CA15.3 - IgM Kit 13

CA15.3 - IgM Kit Product Overview 13

CA19.9 - IgM Kit 14

CA19.9 - IgM Kit Product Overview 14

CEA - IgM Kit - Breast Cancer 15

CEA - IgM Kit - Breast Cancer Product Overview 15

compleXima CRC Biochip 16

compleXima CRC Biochip Product Overview 16

compleXima HCC Biochip - Liver Cancer 17

compleXima HCC Biochip - Liver Cancer Product Overview 17

compleXima Multi Marker Biochip 18

compleXima Multi Marker Biochip Product Overview 18

DCP-IgM Kit - Liver Cancer 19

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Website @ www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ bit.ly/1TBmnVG

This release was published on openPR.